Low risk of adefovir resistance in lamivudine-resistant chronic hepatitis B patients treated with adefovir plus lamivudine combination therapy: two-year follow-up.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples